Searchable abstracts of presentations at key conferences in endocrinology

ea0059s10.1 | Pancreatic NETs – an update | SFEBES2018

Managing Pancreatic Neuroendocrine Tumours in MEN1

Price John Newell

Pancreatic neuroendocrine tumours (pNET) in patients with MEN1 pose a particular and challenging clinical problem. Whilst patients with a pNET and clear clinical and biochemical evidence of hormonal hypersecretion are usually candidates for some form of surgical or medical therapy, the decision-making is far harder for those who are found to have a non-functioning tumour on surveillance imaging. There is a lack of knowledge of the differing biological behaviour between pNETs i...

ea0059n1.2 | Nurse Session 1: Pituitary adenomas; beyond surgery | SFEBES2018

The role of gamma knife in the management of pituitary adenomas

Price John Newell

Pituitary radiotherapy plays an important role in the overall management of pituitary disease, but needs discussion at an expert regional pituitary MDT. Repeat surgical exploration is increasingly performed either as an alternative to radiotherapy or to further reduce tumour bulk ahead of radiotherapy. Careful discussion with the patient on the risks and benefits of radiotherapy, and all the other options, is essential. It is best to consider the control of tumour growth and a...

ea0015p188 | Endocrine tumours and neoplasia | SFEBES2008

Treating an aggressive prolactinoma in a patient with MEN 1: beneficial response to temozolomide

Debono Miguel , Bridgewater Caroline , Ross Richard , Price John Newell

Background: Prolactinomas are usually highly sensitive to dopamine agonists. We report the use of temozolomide in a 47-year-old gentleman with MEN 1 and a highly dopamine agonist-resistant, and aggressive prolactinoma.Case summary: He presented in 2001 with a 3rd nerve palsy and recurrent headaches. MRI revealed a pituitary tumour extending into the left cavernous sinus. Prolactin levels were 29 000 mU/l. (NR<360). Primary hyperparathyroidism, a lesi...

ea0059oc6.3 | Neuroendocrinology and Reproduction | SFEBES2018

Gamma knife radiosurgery for the primary management of acromegaly

Sims-Williams Hugh , Rajapaksa Kaveesha , Sinha Saurabh , Radatz Matthias , Walton Lee , Yianni John , Price John Newell

Introduction: Trans-sphenoidal Surgery (TSS) remains the primary treatment for acromegaly in most patients, but no previous data exist on outcomes for patients treated with gamma knife radiosurgery (STRS) as a primary treatment.Methods: 20 patients with acromegaly underwent primary STRS at the National Centre for Radiosurgery, Sheffield, UK between 1985 and 2015. Data collection: note review, database, laboratory results, patient questionnaire, and death...

ea0015p166 | Endocrine tumours and neoplasia | SFEBES2008

A cross-sectional study of the influence of somatostatin analogue therapy on the prevalence of gluteal nodules in metastatic mid-gut carcinoid

Debono Miguel , Hon Lye , Bax Nigel , Blakeborough Tony , Price John Newell

Aim: We had noted that certain patients with metastatic mid-gut carcinoid had subcutaneous nodules in the gluteal region. This prompted us to assess this in more detail as the concern was whether these represented metastases.Method: A cross-sectional study was designed to assess CT scans of 56 patients with metastatic mid gut carcinoid attending the Neuroendocrine Tumour Clinic. These were analysed by two independent radiologists blinded as to the treatm...